BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 502967)

  • 1. Blood products.
    Med Lett Drugs Ther; 1979 Nov; 21(23):93-6. PubMed ID: 502967
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal use of blood components and derivatives.
    Walter WJ; Oberman HA
    Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma fractionation in blood transfusion service.
    Haskó F; Salamon M; Bartha K; Dobó P
    Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of blood fractionation in the United States.
    Sgouris JT
    Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
    [No Abstract]   [Full Text] [Related]  

  • 5. Fractionation of plasma with polyethylene glycol.
    Polson A; Ruiz-Bravo C
    Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
    [No Abstract]   [Full Text] [Related]  

  • 6. When should we use blood or blood components?
    Knouse CA
    J Am Osteopath Assoc; 1977 Apr; 76(8):633, 635-9 concl. PubMed ID: 408391
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood component therapy in neonatal medicine.
    Lenes BA; Sacher RA
    Clin Lab Med; 1981 Jun; 1(2):285-309. PubMed ID: 6809397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indications for blood transfusion].
    Hollán Z
    Ter Arkh; 1989; 61(7):113-21. PubMed ID: 2511636
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of plasma derivatives for clinical use.
    Tullis JL
    Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048
    [No Abstract]   [Full Text] [Related]  

  • 10. [New aspects of therapy with blood and blood components].
    Frick U; Frick G
    Zentralbl Chir; 1983; 108(23):1478-84. PubMed ID: 6666422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physiologic basis of the use of blood and blood products.
    Gould SA; Rice CL; Moss GS
    Surg Annu; 1984; 16():13-38. PubMed ID: 6427954
    [No Abstract]   [Full Text] [Related]  

  • 12. 12 simple sensible steps for successful blood transfusions.
    Querin JJ; Stahl LD
    Nursing; 1983 Nov; 13(11):34-43. PubMed ID: 6415556
    [No Abstract]   [Full Text] [Related]  

  • 13. New trends in plasma fractionation.
    Steinbuch M
    Haematologia (Budap); 1983; 16(1-4):39-51. PubMed ID: 6207083
    [No Abstract]   [Full Text] [Related]  

  • 14. Use and abuse of blood.
    Hollán SR
    Ann Acad Med Singap; 1984 Jul; 13(3):502-9. PubMed ID: 6440468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precipitation methods in plasma fractionation.
    Steinbuch M
    Vox Sang; 1972; 23(1):92-106. PubMed ID: 5081018
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the practice and technology of blood transfusion.
    Sandler SG
    Prim Care; 1980 Sep; 7(3):347-67. PubMed ID: 6777791
    [No Abstract]   [Full Text] [Related]  

  • 17. Selected topics in blood component therapy.
    Wallas CH
    Prog Clin Pathol; 1984; 9():47-64. PubMed ID: 6420839
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of chromatography to manufacture purer and safer plasma products.
    Johnston A; Adcock W
    Biotechnol Genet Eng Rev; 2000; 17():37-70. PubMed ID: 11255674
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfusion therapy for patients with cancer.
    Lichtiger B; Huh YO
    CA Cancer J Clin; 1985; 35(5):311-6. PubMed ID: 3930017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.